Paul Kaufman, MD

Education
MD 1967, New York University School of Medicine
Internship, Bellevue Hospital, New York
Residency, Washington University School of Medicine and Barnes Hospital, St. Louis, MO
Fellowship, Ocular Pharmacology, Seeing Eye and National Institutes of Health Research Fellow, Departments of Pharmacology and Physiology, University of Uppsalla, Uppsala, Sweden

Clinical Interests
Glaucoma

Research Interests
Dr. Kaufman’s research centers on studies of the physiology, pharmacology, morphology, cell biology, genetic manipulation, neural control, biomechanics and aging of the aqueous humor formation and drainage and accommodative mechanisms in the non-human primate, seeking to understand the pathophysiology and develop new therapies for the human diseases of glaucoma and presbyopia.  Glaucoma is the second most common cause of irreversible visual loss in adult Americans, the most common among African Americans, and the most common world-wide, while presbyopia is the most common of all ocular afflictions.

In 2018, Dr. Kaufman received the Endre A. Balazs Prize, awarded by the Council of the International Society for Eye Research (ISER) to honor a distinguished scientist whose outstanding contributions provide significant progress in the field of experimental eye research.

Publications
PubMed Listing of Publications